Lactose
- Generic Name
- Lactose
- Drug Type
- Small Molecule
- Chemical Formula
- C12H22O11
- CAS Number
- 63-42-3
- Unique Ingredient Identifier
- 3SY5LH9PMK
- Background
A disaccharide of glucose and galactose in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.
- Indication
Not Available
- Associated Conditions
- Asthma, Chronic Obstructive Pulmonary Disease (COPD), Hypothyroidism, Opioid Dependence, Thyroid Cancer
- Associated Therapies
- Maintenance treatment, opioids, Opioid Detoxification
Prophylaxis of Neuropathic Pain by mémantine
- Conditions
- Neuropathic Pain
- First Posted Date
- 2012-02-22
- Last Posted Date
- 2014-07-01
- Lead Sponsor
- University Hospital, Clermont-Ferrand
- Target Recruit Count
- 43
- Registration Number
- NCT01536314
- Locations
- 🇫🇷
CHU Clermont-Ferrand, Clermont-Ferrand, France
Exploring Learning and Unlearning of Fear
- Conditions
- Healthy Individuals
- Interventions
- First Posted Date
- 2012-01-19
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Registration Number
- NCT01512316
- Locations
- 🇧🇪
Catholic University Leuven, Departement of Radiology, Leuven, Belgium
LIPS-A: Lung Injury Prevention Study With Aspirin
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- First Posted Date
- 2012-01-06
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 400
- Registration Number
- NCT01504867
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Bridgeport Hospital, Bridgeport, Connecticut, United States
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers
- Conditions
- Psychological Effects of Study Drug
- Interventions
- First Posted Date
- 2011-07-28
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Lykos Therapeutics
- Target Recruit Count
- 107
- Registration Number
- NCT01404754
- Locations
- 🇺🇸
Santa Fe MDMA Therapy Training, LLC, Santa Fe, New Mexico, United States
🇺🇸Aguazul Bluewater, Inc., Boulder, Colorado, United States
🇺🇸Zen Therapeutic Solutions, Mount Pleasant, South Carolina, United States
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
- Conditions
- Asthma
- Interventions
- Drug: 100 micrograms Fluticasone propionateDrug: 500 micrograms Fluticasone propionate
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2018-08-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT01400906
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
- Conditions
- Type 1 Diabetes MellitusDiabetic RetinopathyDiabetic Nephropathies
- Interventions
- First Posted Date
- 2011-03-22
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 450
- Registration Number
- NCT01320345
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺Southern Adelaide Diabetes and Endocrine Services, Oaklands Park, South Australia, Australia
🇦🇺University Hospital Geelong, Geelong, Victoria, Australia
Intracranial Pressure in Experimental Models of Headache
- Conditions
- High Altitude Headache
- Interventions
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2012-02-07
- Lead Sponsor
- Bangor University
- Target Recruit Count
- 23
- Registration Number
- NCT01288781
- Locations
- 🇬🇧
School of Sport, Health and Exercise Sciences, Bangor University, Bangor, Gwynedd, United Kingdom
The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
- Conditions
- Non Alcoholic Fatty Liver Disease
- Interventions
- Drug: Omacor
- First Posted Date
- 2011-01-14
- Last Posted Date
- 2014-01-23
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 50
- Registration Number
- NCT01277237
- Locations
- 🇬🇧
Royal Infirmary of Edinburgh, Edinburgh, Lothian, United Kingdom
Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer
- Conditions
- Normal Volunteers
- Interventions
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2010-08-20
- Lead Sponsor
- Chonbuk National University Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT01185418
- Locations
- 🇰🇷
Chonbuk national university hospital, Jeonju, Korea, Republic of
The Effect of Statins in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2010-06-28
- Last Posted Date
- 2014-03-24
- Lead Sponsor
- University of Nottingham
- Target Recruit Count
- 70
- Registration Number
- NCT01151306
- Locations
- 🇬🇧
Nottingham Respiratory Biomedical Research Unit, Nottingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.